Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.426 USD | +1.11% | +5.60% | -45.59% |
09/05 | Transcript : Apyx Medical Corporation, Q1 2024 Earnings Call, May 09, 2024 | |
09/05 | Stavros Vizirgianakis Enters into Letter Agreement with Apyx Medical | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.59% | 4.88Cr | |
-5.26% | 18TCr | |
+1.86% | 11TCr | |
-3.72% | 6.79TCr | |
+4.31% | 5.01TCr | |
+8.59% | 4.43TCr | |
+9.39% | 4.04TCr | |
+24.22% | 3.2TCr | |
-0.54% | 2.58TCr | |
+17.27% | 2.53TCr |
- Stock Market
- Equities
- APYX Stock
- News Apyx Medical Corporation
- Apyx Medical : JMP Securities Adjusts Price Target on Apyx Medical to $14 From $12, Maintains Market Outperform Rating